Anxiety contamination fear
Conditions
Interventions
Augmented Reality exposure
Sponsors
Academisch Medisch Centrum
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: The recruitment of participants takes place as follows. Practitioners at the department of Psychiatry will inform OCD-patients currently being treated or are currently waitlisted for treatment within our institution about our study. If someone is willing to participate in the study, we will personally visit with them at the Psychiatry department to inform them of the entire procedure. Moreover, they will receive an information letter by email that reviews all of the information again in detail in order to ensure that they have the opportunity to fully understand the procedure. If they are still interested in participating, they will sign an informed consent and we will perform screening for inclusion and exclusion criteria. Demographics and clinician-related questionnaires (Y-BOCS, GAF, HAM-D, HAM-A. BABS) will be administered to make sure that the individual can participate. If a participant meets any of the exclusion criteria, then they are excluded from participating in this study.;Inclusion criteria for OCD group: -Men and women. -Age between 25-65. -Recent DSM-V diagnosis (mild, moderate, and severe) of obsessive-compulsive disorder with a primary diagnosis of contamination fear. -Currently in treatment or are waiting for treatment in the AMC department of Psychiatry
Exclusion criteria
Exclusion criteria: Exclusion criteria for OCD participants: - A primary DSM-V diagnosis for any disorder(s) besides contamination-based obsessive-compulsive disorder or other subtype of obsessive-compulsive disorder.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| - AR HMD task, the main study parameters consist of self-reports measured by a VAS and physiological recordings of heart rate and Skin Conductance level (SCL) measured by the VU-AMS. - Traditional Symptom Provocation task, the main study parameters consist of self-reports measured by a VAS and physiological recordings of heart rate and Skin Conductance level (SCL) measured by the VU-AMS. | — |
Countries
Netherlands
Outcome results
None listed